OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.190
-0.190 (-4.34%)
At close: Mar 20, 2026, 4:00 PM EDT
4.580
+0.390 (9.31%)
After-hours: Mar 20, 2026, 7:57 PM EDT
OnKure Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for OnKure Therapeutics stock has a target of 27, which predicts a 544.39% increase from the current stock price of 4.19.
Price Target: $27 (+544.39%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for OnKure Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $27 | Strong Buy | Maintains | $34 → $27 | +544.39% | Mar 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +711.46% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $34 | Strong Buy | Maintains | $40 → $34 | +711.46% | Mar 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $30 | Buy | Maintains | $35 → $30 | +615.99% | Mar 11, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +663.72% | Jan 28, 2025 |
Financial Forecast
Revenue This Year
680.00K
Revenue Next Year
1.02M
from 680.00K
Increased by 50.00%
EPS This Year
-3.80
from -4.40
EPS Next Year
-3.20
from -3.80
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1M | 2.1M | |
| Avg | 680,003 | 1.0M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 208.8% | |
| Avg | - | 50.0% | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.29 | -2.57 | |
| Avg | -3.80 | -3.20 | |
| Low | -4.66 | -4.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.